Diagnostics at the Crossroads: India’s Path to Affordable, High-Impact Healthcare

India’s diagnostics sector is poised for a transformation. From heat-stable reagents that survive extreme climates to point-of-care platforms reaching remote districts, the country is developing solutions that combine affordability, reliability, and scale. Advances in AI, automation, and next-generation biotechnology are also set to strengthen clinical decisions, shorten time-to-treatment, and enhance public-health impact.

In an exclusive interaction with Digital Health News (DHN), Jatin Mahajan, President of the Association of Diagnostics Manufacturers of India (ADMI) and Managing Director of J Mitra & Co, shared his insights on this evolving landscape. With over 55 patents to his credit, Mahajan discussed how Indian diagnostics are moving from laboratories to the frontline, the opportunities and challenges of scaling Make-in-India solutions globally, and the policy reforms needed to expand access to life-saving tests. His perspectives provide a roadmap for building an ecosystem where innovation, affordability, and quality converge, both in India and internationally.

Unlock the Future of Digital Health — Free for 60 Days!

Join DHN Plus and access exclusive news, intelligence reports, and deep-dive research trusted by healthtech leaders.

Already a subscriber? Log in

Subscribe Now @ ₹499.00

Stay tuned for more such updates on Digital Health News